普通外文研报
Komax (1K) | Hold | Leadership change, repositioning continues
研报英文原文证据摘录
Komax (1K) | Hold | Leadership change, repositioning continues
Komax Hold | Target Price: CHF55.00
Outlook clouded
Still anticipating minor improvements from very low levels
Komax has deferred its mid-term targets due to market weakness. While near- and medium-
term financial targets remain official, the team that designed, communicated, and defended
them is largely gone.
FY 2026 is set to be a transition year. The tone is cautious with no granular outlook. However,
the remaining CHF5m cost-out measures are set to come through and, starting from a level of
CHF16m recurring EBIT, the minimum implied EBIT for FY 2026 should be around CHF20m.
We are slightly higher on recurring EBIT. However, we now expect more restructuring and more
one-off costs as well. So far, cost cuts have a fast payback. However, the P&L has already seen
one-off costs in the last two years. Payouts are therefore likely to remain constrained.
The company's primary near-term objective is clear: stay compliant with covenants at all times
and achieve a double-digit EBIT margin from FY 2027 onwards on CHF65m of revenue. This
constitutes a major top-line rebound, which we do not see for now.
However, there are credible margin protection initiatives in place, and in the event of further
end market weakness, the group is likely to intensify efficiency measures.
In fact, Komax now aims to reduce its revenue breakeven point further - even below CHF540m
sales - and it could be reduced even further through additional restructuring (we think this is
likely).
Efficiency measures continue
The company's recovery relies on three pillars.
First, a successful cost transformation: from FY 2026, the cost base should be at least CHF25m
lower than FY 2024 levels, with approximately CHF20m already realised in FY 2025.
本摘录由系统从所标注的 PDF 证据页直接提取并保留英文原文,不做批量翻译;登录后在阅读器切换中文时才按需翻译。
打开研报阅读器